Table 2.
Expression of globo-series GSLs in cancer cell lines
| Tumor origin | SSEA-4+ | SSEA-3+ | Globo H+ | SSEA4+ or SSEA3+ or Globo H+ | SSEA-4+ SSEA-3+ | SSEA-4+ Globo H+ | SSEA-4+ SSEA-3+ Globo H+ |
| Brain | 12/17 | 9/17 | 6/17 | 12/17 | 9/17 | 6/17 | 5/17 |
| Lung | 13/20 | 5/20 | 13/20 | 16/20 | 5/20 | 10/20 | 5/20 |
| Breast | 17/23 | 6/23 | 14/23 | 18/23 | 6/23 | 13/23 | 6/23 |
| Mouth | 8/13 | 2/13 | 11/13 | 12/13 | 2/13 | 7/13 | 2/13 |
| Esophagus | 1/2 | 0/2 | 2/2 | 2/2 | 0/2 | 1/2 | 0/2 |
| Stomach | 4/6 | 3/6 | 6/6 | 6/6 | 3/6 | 4/6 | 3/6 |
| Liver | 6/10 | 4/10 | 9/10 | 9/10 | 4/10 | 6/10 | 4/10 |
| Bile duct | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 1/5 |
| Pancreas | 8/8 | 3/8 | 6/8 | 8/8 | 3/8 | 6/8 | 3/8 |
| Colon | 5/7 | 0/7 | 6/7 | 7/7 | 0/7 | 4/7 | 0/7 |
| Kidney | 5/6 | 0/6 | 5/6 | 6/6 | 0/6 | 4/6 | 0/6 |
| Cervix | 3/4 | 2/4 | 1/4 | 3/4 | 2/4 | 1/4 | 0/4 |
| Ovary | 8/9 | 2/9 | 5/9 | 8/9 | 2/9 | 5/9 | 2/9 |
| Prostate | 4/4 | 1/4 | 1/4 | 4/4 | 1/4 | 1/4 | 0/4 |
Expression of globo-series GSLs was determined by flow cytometry. Cell lines in which more than 15% of total cells were positive in flow cytometry are labeled positive.